Complement Protein-Receptor Interaction Analysis

Creative Biolabs provides comprehensive complement protein-receptor interaction analysis services to help researchers characterize how complement components, activation fragments, engineered biologics, antibodies, inhibitors, and cell-surface receptors interact under physiologically relevant conditions. Creative Biolabs can develop an assay strategy around your scientific question.

Submit Your Request Now

Download our service brochure

Inquiry

Why Complement Protein-Receptor Interactions Matter

The complement system is not merely a soluble cascade of proteolytic activation events. It is also a dynamic communication network between complement proteins and cellular receptors. Complement fragments such as C3b, iC3b, C3d, C3a, C5a, and C1q-related recognition complexes engage receptors expressed on immune cells, endothelial cells, epithelial cells, platelets, and disease-relevant target cells. These interactions can shape phagocytosis, chemotaxis, antigen presentation, B cell activation, immune complex clearance, cytokine release, tissue inflammation, and downstream effector functions. For therapeutic development, understanding these protein-receptor interactions is essential for predicting biological activity, safety liabilities, receptor selectivity, pathway engagement, and mechanism of action.

Our scientists integrate biochemical binding assays, biophysical kinetic methods, cell-based receptor engagement assays, competitive inhibition formats, pathway-specific complement activation systems, and downstream functional readouts to deliver actionable data with clear interpretation.

Great Minds Choose Creative Biolabs

Partner with Us

What We Analyze

Creative Biolabs supports customized interaction studies across a broad range of complement ligands, receptors, therapeutic candidates, and biological systems.

Complement Fragment-Receptor Binding

We evaluate interactions between complement activation fragments and their receptors, including C3b-, iC3b-, C3d-, C3a-, C4b-, C4d-, C5a-, and C1q-associated binding systems. Depending on project goals, we can test purified proteins, receptor ectodomains, receptor-expressing cell lines, primary immune cells, engineered cells, immobilized ligands, or deposited complement fragments generated under serum-based activation conditions.

Complement Receptor Profiling

Our platform can support receptor-specific analysis involving CR1/CD35, CR2/CD21, CR3/CD11b-CD18, CR4/CD11c-CD18, C3aR, C5aR1/CD88, C5aR2, complement regulatory receptors, and other disease-relevant receptor systems. We design assays to distinguish direct ligand binding, competitive displacement, receptor blocking, receptor clustering, and downstream cellular activation.

Antibody and Fc-Engineered Molecule Assessment

Therapeutic antibodies may influence complement biology through C1q recruitment, C3 fragment deposition, Fc-mediated effector functions, receptor-proximal opsonization, or immune complex formation. Creative Biolabs can analyze how antibody candidates, isotypes, subclasses, glycoforms, Fc variants, bispecific antibodies, and immune complexes affect complement ligand-receptor engagement.

Complement Inhibitor Characterization

For small molecules, peptides, aptamers, antibodies, fusion proteins, and other biologics designed to modulate complement, receptor interaction studies can reveal whether inhibition occurs upstream of ligand generation, at the level of ligand-receptor binding, through receptor blockade, or via downstream functional interference.

Cell-Based Receptor Engagement

We can assess receptor engagement on neutrophils, monocytes, macrophages, dendritic cells, B cells, T cells, endothelial cells, epithelial cells, platelets, tumor cells, or engineered receptor-expressing cell lines. Flow cytometry, imaging, reporter systems, and functional cellular assays can be incorporated depending on the receptor and endpoint.

Disease-Relevant Complement Interaction Models

We can customize assay conditions using disease-relevant sera, patient-derived matrices when available, inflammatory stimulation, immune complexes, target cells, biomaterials, or tissue-mimetic surfaces.

Discuss Your Needs

Species and Matrices

Creative Biolabs can develop assays across species and biological matrices according to project needs.

Species

Supported species may include human, non-human primate, mouse, rat, and other species on request.

Matrices

Common matrices include purified buffer systems, serum, cell culture supernatants, and customized activation buffers.

Receptor Systems

Detection schemes can be designed based on various forms of receptors.

Ligand Systems

Ligand types may encompass a wide range of proteins, molecules, particles, microorganisms, or cells.

Workflow of Receptor Ligand Binding Assay

Creative Biolabs provides a structured yet flexible workflow for complement protein-receptor interaction studies. Each project is designed around the biological question, sample type, target receptor, intended decision point, and required data depth.

Workflow of receptor ligand binding assay. (Creative Biolabs Original) Fig. 1 Workflow of complement protein-receptor interaction studies.

Design Your Protocol

Sample Requirements

Sample requirements depend on assay format, target system, and number of conditions. The following guidance can be used for initial planning.

Purified Complement Proteins or Receptors

Recommended concentration: project-dependent
Preferred format: purified, low-aggregate, well-characterized protein
Information requested: species, sequence, tag, buffer, purity, storage condition, freeze-thaw history, and known activity
Special considerations: avoid repeated freeze-thaw cycles; provide matched controls if available

Antibodies and Biologics

Sample amount: depending on study size
Information requested: isotype, subclass, Fc engineering, glycosylation notes, formulation buffer, target antigen, and concentration
Special considerations: formulation excipients may affect binding or complement activation; buffer exchange may be recommended

Serum or Plasma

Serum is preferred for complement activation studies
Fresh frozen normal human serum, donor-specific serum, pooled serum, disease serum, or animal serum may be used
Recommended volume: varies by condition number

Cells

Cell type: receptor-expressing cell lines, primary cells, immune cells, tumor cells, endothelial cells, or engineered cells
Information requested: culture conditions, receptor expression data, viability, passage number, treatment history, and shipping requirements
Special considerations: receptor expression and activation state should be verified whenever possible

Add-On Assays That Strengthen Interpretation

Complement receptor interaction data can be paired with additional assays to provide a broader mechanistic picture.

Assays	Descriptions
C1q Binding Assay	C1q binding can help determine whether an antibody, immune complex, pathogen, or surface initiates classical pathway activation. When combined with receptor interaction analysis, it can clarify the relationship between upstream recognition and downstream cellular engagement.
C3b/iC3b/C3d Deposition Assays	Measuring complement fragment deposition provides context for receptor binding. For example, receptor engagement may depend on the amount and type of deposited C3 fragment present on a target surface.
C5a Quantification	C5a production can be measured to determine whether complement activation generates anaphylatoxin signals relevant to C5aR1 or C5aR2 interaction studies.
sC5b-9 Quantification	Terminal pathway activation can be evaluated by measuring soluble C5b-9. This is helpful when receptor interaction data need to be interpreted alongside full cascade progression.
CH50 and AH50 Assays	Classical and alternative pathway functional activity assays can help determine whether candidate molecules alter global complement function.
CDC Assay	Complement-dependent cytotoxicity assays can connect antibody-triggered complement activation to target-cell killing.
Opsonophagocytosis Assay	When C3b or iC3b receptor interactions are central to the question, phagocytosis assays can reveal whether binding supports immune-cell-mediated uptake.
Cytokine Release and Immune Cell Activation	For receptor systems linked to inflammatory signaling, cytokine panels, activation marker analysis, or immune cell stimulation assays can provide additional biological context.

Design Your Customization

Case Studies

Case 1

Purified C3b triggers phagocytosis and killing of E. coli by human neutrophils via complement receptor 1

The researchers employ serum-free methods to couple purified complement C3b onto E. coli bacteria and beads and then expose human neutrophils to these C3b-coated targets. They examine the neutrophil response using a combination of flow cytometry, confocal microscopy, luminometry, single-live-cell/single-target manipulation, and dynamic analysis of neutrophil spreading on opsonin-coated surfaces. We show that purified C3b can potently trigger phagocytosis and killing of bacterial cells via Complement receptor 1.

Purified C3b triggers phagocytosis and killing of E. coli via CR1. (OA Literature) Fig. 2 C3b-labelled beads directly interact with human neutrophils via complement receptor 1.^1,2

References

Boero, Elena, et al. "Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement receptor 1." Scientific Reports 13.1 (2023): 274. https://doi.org/10.1038/s41598-022-27279-4
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We were developing a complement-modulating biologic and needed to understand whether our lead candidates interfered with ligand-receptor engagement. Creative Biolabs helped us select the right assay format, optimize the receptor presentation strategy, and interpret the results in the context of complement pathway biology. The final report was clear, detailed, and useful."

— Scientist, Biologics Discovery Company

"Our project required more than a simple binding assay. We needed to know whether receptor engagement translated into downstream cellular activity. Creative Biolabs combined receptor binding analysis with cell-based functional readouts, which helped us prioritize candidates with stronger translational potential."

— Director, Immunology Research Program

"Complement assays can be difficult to interpret because ligand form, receptor density, serum conditions, and surface presentation all matter. The Creative Biolabs team recognized these challenges and designed controls that made the data much more reliable. Their expertise saved us significant assay development time."

— Principal Investigator, Academic Medical Center

"We submitted multiple antibody candidates for complement receptor interaction profiling. Creative Biolabs established a practical screening workflow that allowed us to compare binding profiles, receptor specificity, and inhibitory potential across our panel. The turnaround and communication were excellent."

— Senior Research Manager, Antibody Therapeutics Company

Frequently Asked Questions

How do you choose the best assay format for a complement protein-receptor interaction study?

The best format depends on the question. If you need rapid screening or dose-response comparison, ELISA-based binding may be appropriate. If you need kinetic parameters, SPR or BLI is preferred. If receptor density, cell context, or endogenous expression matters, flow cytometry or cell-based assays are more informative. If the receptor triggers signaling, functional assays such as calcium flux, chemotaxis, cytokine release, or reporter activation may be needed.

Can you analyze both purified receptor-ligand binding and cell-surface receptor engagement?

Yes. We can work with purified proteins, recombinant receptor ectodomains, tagged receptors, receptor-Fc fusions, engineered cell lines, and primary receptor-positive cells. Many projects use purified systems for controlled binding analysis and cell-based systems for biological validation.

What controls are recommended?

Controls depend on assay format, but commonly include no-ligand controls, no-receptor controls, irrelevant protein controls, known positive controls, blocking antibodies, receptor-negative cells, heat-inactivated serum, complement-depleted serum, and competition with excess ligand. Creative Biolabs will recommend an appropriate control panel during assay design.

Can receptor interaction analysis be combined with C3b deposition or C5a measurement?

Yes. Combining receptor interaction analysis with complement deposition and activation product measurements often provides stronger mechanistic interpretation. For example, C3b/iC3b deposition can explain receptor engagement, while C5a quantification can provide context for C5a receptor activation studies.

What is the typical project timeline?

The timeline depends on assay complexity, reagent availability, number of samples, species, matrix, and whether assay development is required. A straightforward binding assay may be completed faster than a fully customized kinetic and functional validation package. Creative Biolabs can design phased workflows to support discovery milestones.

What information should I provide when requesting a quote?

Please provide the receptor and ligand of interest, species, sample type, therapeutic modality, desired assay format if known, number of samples, required endpoints, matrix preference, available controls, and project objective. If you are unsure which assay is best, our scientists can help design a suitable strategy.